IRIS
RASPADORI, DONATELLA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.893
EU - Europa 2.446
AS - Asia 1.425
SA - Sud America 264
Continente sconosciuto - Info sul continente non disponibili 109
AF - Africa 82
OC - Oceania 6
Totale 7.225
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.828
RU - Federazione Russa 677
SG - Singapore 466
CN - Cina 439
IT - Italia 397
GB - Regno Unito 357
IE - Irlanda 329
BR - Brasile 222
SE - Svezia 188
VN - Vietnam 139
DE - Germania 118
FR - Francia 118
HK - Hong Kong 103
UA - Ucraina 90
FI - Finlandia 67
KR - Corea 66
IN - India 54
CA - Canada 39
ZA - Sudafrica 37
BD - Bangladesh 34
TR - Turchia 23
MX - Messico 19
ES - Italia 18
IQ - Iraq 18
JP - Giappone 18
PL - Polonia 17
AR - Argentina 15
NL - Olanda 15
BE - Belgio 12
CZ - Repubblica Ceca 11
NG - Nigeria 9
KE - Kenya 8
AT - Austria 7
MA - Marocco 7
PK - Pakistan 7
PY - Paraguay 7
AU - Australia 6
EG - Egitto 6
JO - Giordania 6
UZ - Uzbekistan 6
CI - Costa d'Avorio 5
ID - Indonesia 5
SA - Arabia Saudita 5
VE - Venezuela 5
EC - Ecuador 4
IR - Iran 4
MY - Malesia 4
CL - Cile 3
DZ - Algeria 3
GR - Grecia 3
KG - Kirghizistan 3
LT - Lituania 3
PH - Filippine 3
SK - Slovacchia (Repubblica Slovacca) 3
AE - Emirati Arabi Uniti 2
BN - Brunei Darussalam 2
BO - Bolivia 2
CO - Colombia 2
CR - Costa Rica 2
EE - Estonia 2
ET - Etiopia 2
IL - Israele 2
JM - Giamaica 2
KH - Cambogia 2
LB - Libano 2
LV - Lettonia 2
NO - Norvegia 2
OM - Oman 2
PE - Perù 2
PS - Palestinian Territory 2
PT - Portogallo 2
SC - Seychelles 2
TN - Tunisia 2
UY - Uruguay 2
AL - Albania 1
AZ - Azerbaigian 1
BG - Bulgaria 1
BY - Bielorussia 1
DO - Repubblica Dominicana 1
GA - Gabon 1
GE - Georgia 1
KW - Kuwait 1
LK - Sri Lanka 1
LU - Lussemburgo 1
MD - Moldavia 1
MK - Macedonia 1
NP - Nepal 1
PA - Panama 1
QA - Qatar 1
RO - Romania 1
RS - Serbia 1
SY - Repubblica araba siriana 1
TH - Thailandia 1
TT - Trinidad e Tobago 1
Totale 7.116
Salva come PNG Salva come JPEG
Città #
Dublin 327
Singapore 303
Southend 295
Dallas 263
Fairfield 257
Ashburn 241
San Jose 213
Moscow 180
Santa Clara 164
Chandler 145
Woodbridge 111
Beijing 109
Milan 108
Seattle 106
Houston 100
Hong Kong 99
Hefei 98
Wilmington 85
Council Bluffs 80
Ann Arbor 79
Cambridge 77
Jacksonville 72
Seoul 66
Munich 58
The Dalles 55
Los Angeles 51
Siena 50
Princeton 43
Ho Chi Minh City 40
New York 37
Lauterbourg 36
Hanoi 34
Helsinki 34
Rome 33
Johannesburg 32
Columbus 28
São Paulo 25
Nanjing 20
Orem 20
San Mateo 20
Turku 20
Florence 19
Figino 18
San Diego 18
Bengaluru 16
Dearborn 16
Izmir 16
Shanghai 16
Buffalo 15
Boardman 14
London 14
Tokyo 14
Chennai 13
Frankfurt am Main 13
Dong Ket 12
Toronto 12
Brussels 11
Redondo Beach 11
Brno 10
Denver 10
Montreal 10
Phoenix 10
Turin 10
Warsaw 10
Abuja 9
Brooklyn 9
Chicago 9
San Francisco 9
Shenyang 9
Atlanta 8
Nuremberg 8
Porto Alegre 8
Stockholm 8
Düsseldorf 7
Lappeenranta 7
Nanchang 7
Amman 6
Baghdad 6
Belo Horizonte 6
Jinan 6
Miami 6
Poplar 6
Querétaro 6
Tashkent 6
Washington 6
Abidjan 5
Biên Hòa 5
Brasília 5
Cairo 5
Changsha 5
Charlotte 5
Curitiba 5
Da Nang 5
Haiphong 5
Messina 5
Mexico City 5
Rio de Janeiro 5
Tianjin 5
Vienna 5
Boston 4
Totale 4.748
Salva come PNG Salva come JPEG
Nome #
Flow Cytometry Assessment of CD26+ Leukemic Stem Cells in Peripheral Blood: A Simple and Rapid New Diagnostic Tool for Chronic Myeloid Leukemia 322
Residual peripheral blood CD26+leukemic stem cells in chronic myeloid leukemia patients during TKI therapy and during treatment-free remission 301
Multicentre phase III trial on fludarabine, cytarabine (Ara-C), and idarubicin versus idarubicin, Ara-C and etoposide for induction treatment of younger, newly diagnosed acute myeloid leukaemia patients. 285
Ectopic ILT3 controls BCR-dependent activation of Akt in B-cell chronic lymphocytic leukemia 285
Long-Term Safety of Rapid Daratumumab Infusions in Multiple Myeloma Patients 259
Insight into the behavior of hairy cell leukemia by immunogenetic analysis 252
Clinical impact of CD200 expression in patients with acute myeloid leukemia and correlation with other molecular prognostic factors 251
High CD200 expression is associated with poor prognosis in cytogenetically normal acute myeloid leukemia, even in FlT3-ITD-/NPM1+ patients 243
Study of gene polymorphisms as predictors of treatment efficacy and toxicity in patients with indolent non-hodgkin lymphomas and mantle cell lymphoma receiving bendamustine and rituximab 243
A BRAF Negative Classic Hairy Cell Leukemia Patient in Long Lasting Complete Remission after Rituximab and Pentostatin 236
A case of acute myelogenous leukemia: myelodysplastic syndrome with t(2;11)(p21;q23) without MLL rearrangement 231
A t(20;21)(q12;q22.3) in a patient with chronic myelocytic leukemia in blastic phase [3] 217
First reported case of secondary mixed phenotype acute leukemia after multiple myeloma 212
Anti CD38 monoclonal antibodies for multiple myeloma treatment 210
Cladribine Efficacy in a Patient with Hairy Cell Leukemia and Severe Renal Insufficiency 204
An unusual presentation of chronic B-cell lymphocytic leukaemia 203
Minimal residual disease in multiple myeloma: State of the art and applications in clinical practice 195
Fludarabine in patients with advanced and/or resistant B‐chronic lymphocytic leukemia 194
CD56 and PGP expression in acute myeloid leukemia: impact on clinical outcome 178
V-H and V-L genes in hairy cell leukemia reveal a dynamic on-going modification of the surface B-cell receptor 177
The role of MDR-related proteins in the prognosis of adult acute myeloid leukaemia (AML) with normal karyotype 173
Peripheral Blood CD26+ Leukemia Stem Cells Monitoring in Chronic Myeloid Leukemia Patients from Diagnosis to Response to TKIs: Interim Results of a Multicenter Prospective Study (PROSPECTIVE FLOWERS) 162
DART4MM: Daratumumab as Consolidation Therapy in Patients who Already Achieved Optimal Response/MRD Positivity by Next Generation Flow (NGF): Preliminary Results of a Phase 2 Multicenter Study 161
Minimal Residual Disease Detection at RNA and Leukemic Stem Cell (LSC) Levels: Comparison of RT-qPCR, d-PCR and CD26+ Stem Cell Measurements in Chronic Myeloid Leukemia (CML) Patients in Deep Molecular Response (DMR) 160
Complete resolution of hepatic aspergillosis after non-myeloablative hematopoietic stem cell transplantation in a patient with acute myeloid leukemia 154
Selection and Transplantation of Autologous Hematopoietic CD34+ Cells for Patients with Multiple Myeloma 151
The prognostic role of gene polymorphisms in patients with indolent non-Hodgkin lymphomas and mantle-cell lymphoma receiving bendamustine and rituximab: results of the 5-year follow-up study 150
Trisomy 8 in chronic lymphocytic leukemia: a report of two cases 148
Prognostic value of CD47 overexpression measured by flow cytometry in acute myeloid leukemia 148
Low-dose oral fludarabine plus cyclophosphamide as first-line treatment in elderly patients with indolent non-Hodgkin lymphoma 147
“Friends and foes” of multiple myeloma measurable/minimal residual disease evaluation by next generation flow 141
Peripheral Blood Flow-Cytometry Chronic Myeloid Leukemia Stem Cells Detection and Quantification during Tyrosine Kinase Inhibitors Therapy 141
Prospective Monitoring of Peripheral Blood CD26+ Leukemia Stem Cells in Chronic Myeloid Leukemia Patients from Time of TKI Discontinuation 140
Minimal Residual Disease Significance in Multiple Myeloma Patients Treated with Anti-CD38 Monoclonal Antibodies 136
Relationship between immunological response to alpha-IFN treatment in 35 patients with hairy cell leukemia 134
Unravelling a clinical role of peripheral blood leukemia stem cells at diagnosis in chronic myeloid leukemia patients: Final results of prospective FLOWERS study 98
Tp53 disruptions: Is there a marker of poor prognosis in chronic lymphoproliferative disorders? 97
MRD-negative conversion with daratumumab monotherapy in newly diagnosed multiple myeloma patients in ≥VGPR/MRD-positive after first-line therapy: Final analysis of the open-label, single-arm multicentric phase 2 trial DART4MM 36
Reply to “Peripheral blood CD26+ leukemic stem cells in chronic myeloid leukemia and tyrosine kinase inhibitor response: Questions remain!” 35
Bone marrow immune cell composition reflects multiple myeloma progression and affects treatment response 15
Totale 7.225
Salva come PNG Salva come JPEG
Categoria #
all - tutte 23.970
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 23.970
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022312 0 0 26 66 20 15 11 10 13 39 42 70
2022/2023547 31 56 74 70 51 98 14 69 46 12 23 3
2023/2024538 13 11 54 42 20 132 190 6 2 16 8 44
2024/20251.096 28 42 138 60 121 71 26 49 77 50 130 304
2025/20262.938 205 340 247 435 631 108 292 63 77 183 93 264
2026/2027244 100 72 72 0 0 0 0 0 0 0 0 0
Totale 7.225